CNR Institutional Research Information System

ULGHERI, FAUSTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.432
NA - Nord America 1.025
EU - Europa 395
SA - Sud America 259
AF - Africa 33
OC - Oceania 2
Totale 3.146
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 992
SG - Singapore 618
CN - Cina 291
BR - Brasile 208
VN - Vietnam 147
HK - Hong Kong 140
IT - Italia 132
JP - Giappone 82
FR - Francia 74
KR - Corea 43
NL - Olanda 35
GB - Regno Unito 31
DE - Germania 30
IN - India 26
FI - Finlandia 21
AR - Argentina 20
BD - Bangladesh 17
ZA - Sudafrica 15
TR - Turchia 13
CA - Canada 12
ES - Italia 12
MX - Messico 9
EC - Ecuador 8
IL - Israele 8
AT - Austria 7
CO - Colombia 7
IQ - Iraq 7
PL - Polonia 7
SE - Svezia 7
VE - Venezuela 7
ID - Indonesia 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
IE - Irlanda 5
RU - Federazione Russa 5
UA - Ucraina 5
KE - Kenya 4
MA - Marocco 4
PK - Pakistan 4
BE - Belgio 3
CZ - Repubblica Ceca 3
RO - Romania 3
TW - Taiwan 3
BG - Bulgaria 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
LB - Libano 2
LT - Lituania 2
NI - Nicaragua 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
SV - El Salvador 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BJ - Benin 1
CG - Congo 1
CH - Svizzera 1
CL - Cile 1
CU - Cuba 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
JE - Jersey 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MM - Myanmar 1
MR - Mauritania 1
MT - Malta 1
MV - Maldive 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
QA - Qatar 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 3.146
Salva come PNG Salva come JPEG
Città #
Santa Clara 423
Singapore 355
Hong Kong 138
Hefei 105
Beijing 83
San Jose 77
Tokyo 75
Ashburn 66
Lauterbourg 60
Los Angeles 55
Ho Chi Minh City 48
Seoul 41
Dallas 34
Hanoi 34
New York 27
Rome 20
Cavallino 19
Amsterdam 16
Genoa 13
Orem 13
São Paulo 13
Buffalo 12
Munich 12
Atlanta 10
Brooklyn 10
Johannesburg 10
Da Nang 9
Boardman 8
Brasília 8
Helsinki 8
Milan 8
Naples 8
Turku 8
Chennai 7
Frankfurt am Main 7
Haiphong 7
Istanbul 7
London 7
Rio de Janeiro 7
Stockholm 7
Warsaw 7
Houston 6
Minamishinagawa 6
Montreal 6
Vienna 6
Bengaluru 5
Casandrino 5
Council Bluffs 5
Denver 5
Dublin 5
Florence 5
Fortaleza 5
Phoenix 5
Tashkent 5
Can Tho 4
Hải Dương 4
Lappeenranta 4
Nairobi 4
Santo André 4
Ankara 3
Bogotá 3
Campinas 3
Chicago 3
City of London 3
Contagem 3
Delhi 3
Dhaka 3
Guangzhou 3
Guayaquil 3
Ha Long 3
Karachi 3
Kyiv 3
Manchester 3
Mauá 3
Mumbai 3
Poplar 3
Porto Alegre 3
Ribeirão Preto 3
Sala Baganza 3
Salvador 3
San Francisco 3
Sestu 3
São Bernardo do Campo 3
Vũng Tàu 3
Abidjan 2
Alghero 2
Araçatuba 2
Baghdad 2
Bagé 2
Bakersfield 2
Belo Horizonte 2
Birigui 2
Birmingham 2
Biên Hòa 2
Blumenau 2
Boston 2
Bucharest 2
Bình Dương Province 2
Bến Cầu 2
Camp Verde 2
Totale 2.078
Salva come PNG Salva come JPEG
Nome #
Enhanced G-quadruplex ligand screening exploiting high-throughput synchrotron radiation circular dichroism 94
PNRR PE13 INF-ACT: Development of Immunomodulatory and Antiviral Lead Compounds 85
Definizione e realizzazione di una nuova procedura sintetica per la preparazione di eterocicli azotati 84
Synthesis of indole derivatives by domino hydroformylation/indolization of 2-nitrocinnamaldehydes 84
Rapid G4 Ligand Screening Through Spectral Changes Using HT-SRCD with Minimal Material 75
Use of 1,3-dibenzyl-dihydrouracil in the chain extension of 2,3-O-isopropylidene-D-glyceraldehyde 74
Design and synthesis of a new Non-Covalent Caspase-3 Inhibitor with Neuroprotective Property 74
High-Throughput Synchrotron Radiation Circular Dichroism (HT-SRCD) for the screening of G-quadruplex ligands 72
"Green Chemistry" in "Drug Discovery": sintesi sostenibili di nuovi inibitori di telomerasi 68
SYNTHESIS AND ENANTIOMERIC SEPARATION OF A NOVEL SPIROKETAL DERIVATIVE: A POTENT HUMAN TELOMERASE INHIBITOR WITH HIGH IN VITRO ANTICANCER ACTIVITY 68
A new synthetic spiroketal: Studies on antitumor activity on murine melanoma model in vivo and mechanism of action in vitro 65
Design, synthesis and biological evaluation of 1,5-disubstituted aamino tetrazole derivatives as non-covalent inflammasome-caspase-1 complex inhibitors with potential application against immune and inflammatory disorders 64
A New synthetic spiroketal: Antitumor Activity On Murine Melanoma Model In Vivo and MOA In Vitro 63
Non-covalent inflammasome-caspase-1 complex inhibitors: New molecules targeting immune and inflammatory disorders including COVID-19 61
5-Trihydroxypropyl-dihydrouracil derivatives as precursors of 1-azasugars: application to the stereoselective synthesis of D-galacto-isofagomine 60
Caspasi, Miastenia Gravis e Distrofia Muscolare di duchenne 59
Potent Non-Covalent Inhibitors of Caspase-1 Targeting Neuroinflammation in Neurodegenerative Diseases 56
2-hydroxy-8-methyl-1,7-dioxaspiro[5.5]undec-3-en-5-one: a Natural-Product-Inspired Spiroketal with in vivo Efficacy in Mouse Model of Melanoma 55
Synthesis and Enantiomeric Separation of a Novel Spiroketal Derivative: A Potent Human Telomerase Inhibitor with High in Vitro Anticancer Activity 54
An Efficient Chemical Conversion of Glycerol to Dihydroxyacetone 53
Novel therapeutic approach in a multiplicity of neurodegenerative and autoinflammatory pathologies 52
"Design and Synthesis of New Bioactive Molecules in Drug Discovery" 52
Novel caspase inhibitors 50
Enantioselective addition of diethylzinc to benzaldehyde in the presence of sulfur-containing pyridine ligands 47
Method for the selective oxidation of glycerol to dihydroxyacetone 46
Short and highly stereoselective total synthesis of D-ribo-configured ureido sugars 45
TARGETING NEUROINFLAMMATION THROUGH POTENT NON-COVALENT INHIBITORS OF CASPASE-1 43
Individuazione di Nuovi Lead per la Cura di Patologie Neurodegenerative 43
Efficient Total Syntheses of (lR, 2R, 3R, 9R, 9aR)-1,2,3,9- Tetrahydroxyquinolizidine and Its Enantiomer 41
Sintesi stereoselettiva di sulfonammidi 40
Synthesis and Enantiomeric Separation of a Novel Spiroketal Derivative: A Potent Human Telomerase Inhibitor with High in Vitro Anticancer Activity. 38
Synthesis of dihydropyridine and piperidine derivatives via an unexpected reaction of pyridine with acetyl chloride 37
Nuova procedura di sintesi di derivati metil piridinici. 37
Enantiomerically pure 1-(2-methoxy-1-naphthyl) and 1-(2-methylthio-1-naphthyl)isoquinoline: two new axially chiral N-O and N-S ligands for asymmetric catalysis 36
Divergent synthesis of 3-amino-3-deoxy- and 4-amino-4-deoxyhexoses 36
An unexpected reaction of pyridine with acetyl chloride to give dihydropyridine and piperidine derivatives 36
Potent non-covalent inhibitors of Caspase-1 35
Sintesi di derivati biciclici di interesse farmacologico 35
Total Synthesis of 2,3-Dideoxy-C-Methylheptose Derivatives 35
Diastereoselective synthesis of 5-(alditol-1-C-yl)-hydantoins and their use as precursors of polyhydroxylated a-amino acids 34
Enantioselective synthesis of enantiomerically enriched compounds 34
Total Syntheses of All Four Isomers of cis- 1,Z-Dihydroxypyrrolizidine 34
Sintesi di derivati benzociclopentanici 34
Advances in asymmetric synthesis of biologically active molecules using heterocycles as building blocks 34
Definizione di una nuova procedura sintetica per la preparazione di diammine cicliche sostituite 34
Sintesi di eterocicli ossigenati e azotati dotati di funzionalità carbossilica 34
Design and synthesis of new bioactive molecules in drug discovery 33
Synthetic Approaches to Carbohydrate-Based Ureas 33
Nuova procedura di sintesi di derivati ammino-piridinici 33
Enantioselective Synthesis of (S)- and (R)-Tolterodine by Asymmetric Hydrogenation of a Coumarin Derivative Obtained by a Heck Reaction 32
Sintesi di derivati di ammine cicliche 32
Definizione di una nuova procedura sintetica per la preparazione di diammine cicliche a n-termini 31
Synthesis and Analysis of Leu- and Met-Enkephalin Analogues Containing Conformational Restriction 31
Avanzamenti nella sintesi di derivati biciclici di interesse farmacologico 31
Diastereoselective synthesis of 5-(alditol-1-C-yl)-hydantoins and their use as precursors of polyhydroxylated alpha-amino acids 31
Individuazione di Nuovi Lead per la Cura di Patologie Neurodegenerative 30
Asymmetric Synthesis of 4-Amino-2,3,4- trideoxyaldonic Acids: Novel GABA C-Glycoconjugates 29
Selective Reactions using N-(tert-Butoxycarbonyl)-2-(tert-butyldimethylsiloxy) pyrrole: Concise Asymmetric Syntheses of (+)-I -Deoxy- 8-epi-castanospermine and its Enantiomer 29
Sintesi di alfa-amminoacidi conformazionalmente costretti 29
Sintesi di ammidi cicliche 29
Sintesi di eterocicli azotati sostitutiti 29
Sintesi di derivati piridinici 28
Sintesi Stereoselettiva di Ureido-Zuccheri via 5-(Alditol-1-C-il)Idantoina Building Blocks. Effetto del Gruppo Protettivo dell Idantoina sulla Diastereoselettività 28
Definizione e realizzazione di una nuova procedura sintetica per la sintesi di ammidi cicliche sostituite 28
Enantioselective hydrogenation of a key intermediate useful for the synthesis of (+)(R)-Tolterodine 28
Sintesi di derivati biciclici di interesse farmacologico III 28
Sintesi di derivati ciano-piridinici. 27
Expeditious Synthesis of the Key Unnatural Aminoacid in the Formal Asymmetric Total Synthesis of (-)-Jorumycin and Bioactive Tetrahydroisoquinoline Alkaloids 27
TOTAL SYNTHESES OF N-BOC-PROTECTED 3'-DEOXY-4'-AZATHYMIDINE AND 4'-AZAURIDINE 26
Iron Complexes as Catalysts in Aldol Additions 26
Method for the selective oxidation of glycerol to dihydroxyacetone 25
Report finale: Sintesi di derivati biciclici di interesse farmacologico 24
Total Syntheses of (+)-2,8,8a-Tri-epi-swainsonine and (-)-1-epi-Swainsonine 24
Totale 3.171
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.607
article - articoli 3.604
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 106
Totale 13.317
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202436 0 0 0 0 0 0 0 0 5 2 22 7
2024/20251.239 13 3 87 37 344 84 8 63 29 41 281 249
2025/20261.837 84 157 177 335 323 92 248 86 153 115 40 27
2026/202759 59 0 0 0 0 0 0 0 0 0 0 0
Totale 3.171